Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Community Based Intervention

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

Psychodynamic Therapy

Psychodynamic Therapy

Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Journal of psychopharmacology (Oxford, England)·2025

Same author

On Minimizing Risk and Harm in the Use of Psychedelics.

Psychiatric research and clinical practice·2025

Same author

Relationality and Ethics in MDMA-Assisted Therapy.

The American journal of bioethics : AJOB·2025

Same author

Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement.

JAMA network open·2024

Same author

Call for evidence-based psychedelic integration.

Experimental and clinical psychopharmacology·2023

Same author

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

JAMA·2023

Search research articles

Related Experiment Video

Updated: Jun 5, 2025

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.

Xiaojue Hu¹, Ingmar Gorman², Elizabeth Nielson²

¹New York University School of Medicine, New York, NY, USA.

Current Topics in Behavioral Neurosciences

|December 9, 2024

Summary

Psychedelic Harm Reduction and Integration (PHRI) provides a clinical model for therapists to help clients prepare for and integrate psychedelic experiences. This approach focuses on empowering clients and reducing harm without direct psychedelic administration.

Keywords:

Harm reduction Inner-directed approach Nonordinary states of consciousness Psychedelic integration Transtheoretical model

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Related Experiment Videos

Last Updated: Jun 5, 2025

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Area of Science:

Clinical Psychology
Psychotherapy Research
Psychedelic Studies

Background:

Psychedelic experiences in therapeutic settings require specialized clinical support.
Existing models may not fully address the preparation and integration phases.
Harm reduction principles are crucial for managing psychedelic experiences.

Purpose of the Study:

Introduce the Psychedelic Harm Reduction and Integration (PHRI) model.
Provide a transtheoretical framework for clinicians working with psychedelic experiences.
Outline strategies for preparing clients and integrating psychedelic insights.

Main Methods:

Drawing from harm reduction psychotherapy, psychedelic-assisted therapy, mindfulness, and psychodynamic therapy.
Emphasizing non-pathologizing and client-empowering strategies.
Incorporating principles of non-directive approaches, somatic awareness, and psychological flexibility.

Main Results:

PHRI offers a structured approach to managing both challenging and positive psychedelic experiences.
The model addresses common integration challenges like fear and ego dissolution.
PHRI facilitates the translation of psychedelic experiences into lasting positive changes.

Conclusions:

PHRI provides a comprehensive clinical model for psychedelic harm reduction and integration.
The model bridges various therapeutic modalities to enhance client outcomes.
PHRI supports clinicians in optimizing the therapeutic benefits of psychedelic experiences while minimizing risks.